Michael Kyriakides

Direktör/Styrelseledamot på

Purespring Therapeutics Ltd.

Consumer Services

Finance

Health Technology

Profil

Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.

Aktiva positioner av Michael Kyriakides

Företag	Position	Start
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Direktör/Styrelseledamot	2022-04-01

Alla aktiva positioner av Michael Kyriakides

Tidigare kända positioner av Michael Kyriakides

Företag	Position	Slut
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Privat kapitalinvesterare	-

Se detaljerna i Michael Kyriakidess erfarenhet

Michael Kyriakidess utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Michael Kyriakidess erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Health Technology